Reply to ‘Comment on ‘Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomised controlled VaSera trial’ by Faconti et al.’



;function _(a){var r=t[a];if(void 0!==r)return r.exports;var n=t[a]={exports: